EYVEOD

Serial Number 97463121
733

Registration Progress

Application Filed
Jun 17, 2022
Under Examination
Jul 18, 2023
Approved for Publication
May 23, 2023
Published for Opposition
May 23, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 4 Granted
Due: Jan 18, 2026 173 days

Trademark Image

EYVEOD

Basic Information

Serial Number
97463121
Filing Date
June 17, 2022
Published for Opposition
May 23, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Jul 11, 2025
Application
Pending
Classes
005

Rights Holder

Johnson & Johnson

03
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Ownership History

Johnson & Johnson

Original Applicant
03
New Brunswick, NJ

Johnson & Johnson

Owner at Publication
03
New Brunswick, NJ

Legal Representation

Attorney
Cheryl L. Foytlin

USPTO Deadlines

Next Deadline
173 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
January 18, 2026
Extension Available
Until July 18, 2024

Application History

30 events
Date Code Type Description Documents
Jul 11, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 11, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 11, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 11, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 6, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 6, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 6, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 9, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 9, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 9, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 9, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 10, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 8, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 8, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 8, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 18, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 23, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 23, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 3, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 14, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 13, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 13, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 13, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 16, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 16, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 16, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 14, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 5, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 21, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; pharmaceutical anti-allergic preparations and substances ; vaccines

Classification

International Classes
005